Kidney Transplant [clinicaltrials_resource:d0643f85f44b31f2b90fe9bce648b7f0]
Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients [clinicaltrials:NCT00137345]clinicaltrials:NCT00141037Natural History Study of Azathioprine Adherence [clinicaltrials:NCT00143910]Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients [clinicaltrials:NCT00171496]Prediction of Acute Rejection in Renal Transplant [clinicaltrials:NCT00205257]The Study of Long-term Deterioration of Kidney Transplants. [clinicaltrials:NCT00217126]Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure [clinicaltrials:NCT00223678]Organ Preservation Media Investigation [clinicaltrials:NCT00225472]Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants [clinicaltrials:NCT00257387]Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients [clinicaltrials:NCT00266123]A Study of Factors That Affect Long-Term Kidney Transplant Function [clinicaltrials:NCT00270712]WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients [clinicaltrials:NCT00275314]The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients. [clinicaltrials:NCT00275522]A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients. [clinicaltrials:NCT00275717]PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients [clinicaltrials:NCT00281619]Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM) [clinicaltrials:NCT00296296]EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function [clinicaltrials:NCT00302497]clinicaltrials:NCT00307125Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation [clinicaltrials:NCT00309270]Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant [clinicaltrials:NCT00309309]The Paired Donation Consortium Paired Donation Program [clinicaltrials:NCT00374400]Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients [clinicaltrials:NCT00433953]Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant [clinicaltrials:NCT00466518]MMF vs. AZA for Kidney Transplantation [clinicaltrials:NCT00494741]Melatonin and Adiponectin in Hypertensive Kidney Transplant [clinicaltrials:NCT00498576]clinicaltrials:NCT00502242Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients [clinicaltrials:NCT00537862]Pharmacokinetic Profile of Myfortic (Enteric Coated Mycophenolate Sodium) in a Rapid Steroid Withdrawal Protocol [clinicaltrials:NCT00585468]Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation [clinicaltrials:NCT00642655]clinicaltrials:NCT00659620Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients [clinicaltrials:NCT00663455]Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant [clinicaltrials:NCT00670774]Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS) [clinicaltrials:NCT00676221]Cell-mediated Immune Response to Influenza Vaccine [clinicaltrials:NCT00677547]The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates [clinicaltrials:NCT00722722]Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status [clinicaltrials:NCT00731874]Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance [clinicaltrials:NCT00752479]Protective Immunity Project 02 [clinicaltrials:NCT00833651]clinicaltrials:NCT00895583clinicaltrials:NCT00931255
condition [clinicaltrials_vocabulary:condition]
Kidney Transplant [clinicaltrials_resource:d0643f85f44b31f2b90fe9bce648b7f0]
Bio2RDF identifier
d0643f85f44b31f2b90fe9bce648b7f0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d0643f85f44b31f2b90fe9bce648b7f0
identifier
clinicaltrials_resource:d0643f85f44b31f2b90fe9bce648b7f0
title
Kidney Transplant
@en
label
Kidney Transplant [clinicaltrials_resource:d0643f85f44b31f2b90fe9bce648b7f0]
@en